Trisha L. Houser

868 total citations
13 papers, 666 citations indexed

About

Trisha L. Houser is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Trisha L. Houser has authored 13 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Trisha L. Houser's work include Treatment of Major Depression (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Sexual function and dysfunction studies (3 papers). Trisha L. Houser is often cited by papers focused on Treatment of Major Depression (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Sexual function and dysfunction studies (3 papers). Trisha L. Houser collaborates with scholars based in United States, United Kingdom and Netherlands. Trisha L. Houser's co-authors include Rafe Donahue, Sharyn R. Batey, John A. Ascher, Edmund C. Settle, Harry A. Croft, Vicki J. Foster, Karen L. Weihs, Alan Metz, Carolyn Watson and Lynn Cunningham and has published in prestigious journals such as Biological Psychiatry, The Journal of Clinical Psychiatry and Clinical Therapeutics.

In The Last Decade

Trisha L. Houser

12 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trisha L. Houser United States 8 424 406 236 121 84 13 666
Alan D. Feiger United States 12 447 1.1× 350 0.9× 233 1.0× 64 0.5× 89 1.1× 16 708
J O Cole United States 8 350 0.8× 353 0.9× 147 0.6× 81 0.7× 57 0.7× 10 583
Sharyn R. Batey United States 13 641 1.5× 709 1.7× 347 1.5× 208 1.7× 122 1.5× 26 1.2k
Ursula Reichenpfader United States 7 209 0.5× 199 0.5× 97 0.4× 54 0.4× 70 0.8× 17 482
Vicki J. Foster United States 11 172 0.4× 202 0.5× 98 0.4× 58 0.5× 40 0.5× 15 512
James T. Hartford United States 11 196 0.5× 161 0.4× 188 0.8× 56 0.5× 25 0.3× 16 463
Stephanie C. Koke United States 12 289 0.7× 183 0.5× 133 0.6× 33 0.3× 55 0.7× 19 795
Adam Keller Ashton United States 10 159 0.4× 381 0.9× 50 0.2× 232 1.9× 40 0.5× 19 550
Alessandra Signoretti Italy 7 319 0.8× 306 0.8× 155 0.7× 27 0.2× 91 1.1× 9 730
Vasilios G. Masdrakis Greece 14 142 0.3× 248 0.6× 137 0.6× 37 0.3× 57 0.7× 45 535

Countries citing papers authored by Trisha L. Houser

Since Specialization
Citations

This map shows the geographic impact of Trisha L. Houser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trisha L. Houser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trisha L. Houser more than expected).

Fields of papers citing papers by Trisha L. Houser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trisha L. Houser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trisha L. Houser. The network helps show where Trisha L. Houser may publish in the future.

Co-authorship network of co-authors of Trisha L. Houser

This figure shows the co-authorship network connecting the top 25 collaborators of Trisha L. Houser. A scholar is included among the top collaborators of Trisha L. Houser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trisha L. Houser. Trisha L. Houser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fearon, Ian M., Trisha L. Houser, Xavier Cahours, et al.. (2023). Curiosity and intentions to use myblu e‐cigarettes and an examination of the ‘gateway’ theory: Data from cross‐sectional nationally representative surveys. Drug Testing and Analysis. 15(10). 1257–1269. 1 indexed citations
2.
Fearon, Ian M., Trisha L. Houser, Xavier Cahours, et al.. (2022). Examination of the impact of myblu electronic nicotine delivery system e‐liquid nicotine strength on self‐reported measures of dependence. Drug Testing and Analysis. 15(10). 1270–1280. 2 indexed citations
3.
Weihs, Karen L., Trisha L. Houser, Sharyn R. Batey, et al.. (2002). Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biological Psychiatry. 51(9). 753–761. 54 indexed citations
4.
Croft, Harry A., Trisha L. Houser, Brenda D. Jamerson, et al.. (2002). Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clinical Therapeutics. 24(4). 662–672. 47 indexed citations
5.
Trivedi, Madhukar H., A. John Rush, Thomas Carmody, et al.. (2001). Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients?. The Journal of Clinical Psychiatry. 62(10). 776–781. 56 indexed citations
6.
Dünner, David L., Winghan Jacqueline Kwong, Trisha L. Houser, et al.. (2001). Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release. The Primary Care Companion For CNS Disorders. 3(1). 15 indexed citations
7.
Weihs, Karen L., Edmund C. Settle, Sharyn R. Batey, et al.. (2000). Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly. The Journal of Clinical Psychiatry. 61(3). 196–202. 110 indexed citations
8.
Rush, A. John, Madhukar H. Trivedi, Sharyn R. Batey, et al.. (2000). Anxiolysis associated with antidepressant response to bupropion sustained release or sertraline. European Neuropsychopharmacology. 10. 236–236. 2 indexed citations
9.
Cunningham, Lynn, et al.. (1999). Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.. Annals of Clinical Psychiatry. 11(4). 205–215. 98 indexed citations
10.
Croft, Harry A., Edmund C. Settle, Trisha L. Houser, et al.. (1999). A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clinical Therapeutics. 21(4). 643–658. 188 indexed citations
11.
Coleman, Charles, Vicki J. Foster, Sharyn R. Batey, et al.. (1999). Sexual Dysfunction Associated with the Treatment of Depression: A Placebo-Controlled Comparison of Bupropion Sustained Release and Sertraline Treatment. Annals of Clinical Psychiatry. 11(4). 205–215. 89 indexed citations
12.
Croft, Harry A., et al.. (1999). Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment. European Neuropsychopharmacology. 9. 233–233. 2 indexed citations
13.
Batey, Sharyn R., et al.. (1998). Comparison of the safety and efficacy of bupropion sustained release and paroxetine in elderly depressed outpatients. European Neuropsychopharmacology. 8. S202–S202. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026